• Profile
Close

In vitro maturation (IVM) of oocytes in patients with resistant ovary syndrome and in patients with repeated deficient oocyte maturation

Journal of Assisted Reproduction and Genetics Sep 25, 2018

Galvão A, et al. - Researchers assessed the efficiency of in vitro maturation (IVM) in patients with repeated assisted reproductive technology failure due to resistant ovary syndrome or due to deficient oocyte maturation. They analyzed clinical and laboratory data obtained retrospectively from 28 patients who underwent 49 cycles of IVM between 2010 and 2017. Of these patients, 9 with resistant ovary syndrome underwent 24 IVM cycles and 19 patients with repeated deficient oocyte maturation underwent 25 IVM cycles. Outcomes suggested that IVM is a valuable approach for patients with resistant ovary syndrome. However, for patients with deficient oocyte maturation, it should not be recommended.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay